BELGRADE: Lattice Biologics Ltd. has obtained TSX-V approval to issue 16.76 million common shares of the company to settle outstanding debt. Can$838,000 in debt held by Guy Cook has been converted to equity at a price of Can$0.05 per share and the debt has been extinguished. The common shares are subject to a four-month hold…